The Effects of Glucose Control and Monitor on Inflammation in the Hospitalized Patients With Hyperglycemia
试验速览
- 阶段
- 4 期
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Glucose target
研究概览
简要总结
This study will be conducted in the ward of Taichung Veterans General Hospital. The patient with hyperglycemia in hospitalization will be enrolled by glucose management team.
详细描述
This study will be conducted in the ward of Taichung Veterans General Hospital. The type 2 diabetic patient with hyperglycemia in hospitalization are candidates. The glucose will be controlled using the insulin protocal based on the glucose monitor systems. We will assess the effects of insulin protocal and glucose monitor system on the inpatient with hyperglycemia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetic inpatient
- •Fasting glucose >140 mg/dl or random glucose >180 mg/dl
排除标准
- •incooperative for glucose monitor
- •refusal of insulin
- •pregnancy
研究组 & 干预措施
Insulin protocal
Insulin protocal with convential glucose monitor
干预措施: Insulin protocal (Procedure)
Insulin protocal with CGM
Insulin protocal with continue glucose monitor
干预措施: CONTINUE GLUCOSE MONITOR (Device)
Insulin protocal with CGM
Insulin protocal with continue glucose monitor
干预措施: Insulin protocal (Procedure)
Convential treatment
Convential insulin treatment and glucose monitor
结局指标
主要结局
Glucose target
时间窗: 6 days
The ratio of glucose less than 180 mg/dl
次要结局
- Fasting glucose target(6 days)
- Vascular Cell Adhesion Molecule 1 (VCAM-1)(6 days)
- Brain-Derived Neurotrophic Factor (BDNF)(6 days)
- Hypoglycemia(times)
- Orexin-A(6 days)